Get latest articles and stories on Business at LatestLY. Mumbai (Maharashtra) [India], July 27: Wockhardt Ltd – global pharmaceutical and biotechnology is aiming to turnaround its business operations and has perused important strategic initiatives for the same. Company is eying big on the restructuring of the US Business, vaccine tie-up with Serum for vaccine manufacturing in UK and Novel Antibiotics research to drive the business forward. For the Q4FY23, company posted strong operational performance with 7% Y-o-Y growth in revenue with three fold jump in the EBITDA to Rs. 47 crore. Business News | Wockhardt Ltd Aims to Turnaround Business Operations with Restructuring of US Operations and Vaccine Tie-up with Serum.